Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "PM-pathway control state"

From Bioblast
m (moved Pyruvate&Malate to PM over redirect)
Line 1: Line 1:
{{MitoPedia
{{MitoPedia
|abbr=PM
|abbr=PM
|description='''PM''': [[Pyruvate]] & [[Malate]].
|description='''PM''': [[Pyruvate]] & [[Malate]].


Line 12: Line 11:
}}
}}
{{MitoPedia methods}}
{{MitoPedia methods}}
{{MitoPedia topics
{{MitoPedia SUIT
|mitopedia topic=Respiratory substrate-coupling state
|mitopedia SUIT=SUIT state
}}
}}
{{MitoPedia topics}}
[[File:PM.jpg|right|400px|link=Gnaiger 2014 MitoPathways |Gnaiger 2014 MitoPathways - Chapter 3.2]]
[[File:PM.jpg|right|400px|link=Gnaiger 2014 MitoPathways |Gnaiger 2014 MitoPathways - Chapter 3.2]]
== PM(L) ==
== PM(L) ==

Revision as of 15:33, 25 January 2016


high-resolution terminology - matching measurements at high-resolution


PM-pathway control state

Description

PM: Pyruvate & Malate.

MitoPathway control: CI

SUIT protocol: SUIT-RP1

Pyruvate (P) is oxidatively decarboxylated to acetyl-CoA and CO2, yielding NADH catalyzed by pyruvate dehydrogenase. Malate (M) is oxidized to oxaloacetate by mt-malate dehydrogenase located in the mitochondrial matrix. Condensation of oxaloacate with acetyl-CoA yields citrate (citrate synthase). 2-oxoglutarate (Ξ±-ketoglutarate) is formed from isocitrate (isocitrate dehydrogenase).

Abbreviation: PM

Reference: Gnaiger 2014 MitoPathways - Chapter 3.2



Template:MitoPedia SUIT


Gnaiger 2014 MitoPathways - Chapter 3.2

PM(L)

  • SUIT-RP1: 1PM 2D 2c (2NADH) 3U 4Oct 5G 6S 7Rot 8Gp 9Ama 10Tm

PM(P)

  • SUIT-RP1: 1PM 2D 2c (2NADH) 3U 4Oct 5G 6S 7Rot 8Gp 9Ama 10Tm

PM(E)

  • SUIT-RP1: 1PM 2D 2c (2NADH) 3U 4Oct 5G 6S 7Rot 8Gp 9Ama 10Tm


CI-linked linear coupling control: L – P - E

  • L - P
OXPHOS coupling efficiency (P-L or β‰ˆP control factor), jβ‰ˆP = β‰ˆP/P = (P-L)/P = 1-L/P, is measured in the CI-linked substrate state, with defined coupling sites (CI, CIII, CIV) and at high flux.
  • P - E
CCCP is titrated stepwise to maximum flux, to evaluate limitation of OXPHOS by the phosphorylation system, expressed as the apparent excess E-P capacity factor (E-P coupling control factor), jExP = (E-P)/E = 1-P/E. If jExP>0, then the ETS coupling efficiency rather than the OXPHOS coupling efficiency is the proper expression of coupling, jβ‰ˆE = β‰ˆE/E = (E-L)/E = 1-L/E.


Discussion

  • Pyruvate alone is not an ETS competent substrate state in most mt-preparations, since acetyl-CoA accumulates without the co-substrate (oxaloacetate) of citrate synthase.
  • Malate alone is not an ETS competent substrate state in many mt-preparations, since oxaloacetate accumulates without the co-substrate (acetyl-CoA) of citrate synthase.